You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 28 No. 6, June 1973 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (22)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Residential Psychedelic (LSD) Therapy for the Narcotic Addict

A Controlled Study

Charles Savage, MD; O. Lee McCabe, PhD

Arch Gen Psychiatry. 1973;28(6):808-814.


Abstract

A controlled investigation was made of the rehabilitative efficacy of brief residential psychedelic (LSD) psychotherapy with chronic heroin abusers. Seventy-eight volunteer addict inmates from Maryland correctional institutions were randomly assigned to the following: a treatment condition–psychedlic therapy (incorporating one high-dose LSD administration) during a six weeks residence in a halfway house type of facility; or a control condition–an outpatient clinic program including daily urine monitoring and weekly group psychotherapy. All subjects (37 completers in each group) were treated identically save for the initial six-week period of residential treatment. Major outcome criteria were based on evaluative assessments (including daily urine surveillance) of the treatment and control groups covering the 12 months following discharge to the community. Comparative verified abstinence data throughout the first posttreatment year were significantly in favor of the treatment group.



Author Affiliations

Baltimore

From the Drug Abuse Program, Veterans Administration Hospital and University of Maryland (Dr. Savage) and the Addiction Research Division, Maryland Psychiatric Research Center, Maryland Department of Health and Mental Hygiene, and Loyola College (Dr. McCabe), Baltimore.


Footnotes

Accepted for publication Jan 22, 1973.

Reprint requests to Maryland Psychiatric Research 3235, Baltimore, MD 21228 (Dr. Savage).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
Griffiths et al.
J Psychopharmacol 2008;22:621-632.
ABSTRACT  

Human hallucinogen research: guidelines for safety
Johnson et al.
J Psychopharmacol 2008;22:603-620.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1973 American Medical Association. All Rights Reserved.